Overview
- Crescent Pharma is recalling batch GR164099 of Ramipril 5 mg capsules after a packaging mix-up placed Amlodipine 5 mg blister strips in some cartons.
- The MHRA instructs pharmacies and healthcare providers to remove the affected batch from shelves and return remaining stock to suppliers.
- Patients taking ramipril should check their carton for GR164099 and return any pack that contains blister strips labeled “Amlodipine” to a pharmacist.
- The MHRA says the error likely occurred during secondary packaging at the same site that manufactures both medicines.
- Suspected adverse reactions should be reported via the MHRA Yellow Card scheme, with dizziness from low blood pressure identified as the most likely effect.